Core One Labs logo

Core One Labs(OTC) CLABF

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-100%
5 Year-100%
1 Year-100%
1 Month+0%
$0.00
+0.00%
+0.00Today
Core One Labs last closing stock price
MetricPriceDate
Last closeUSD 0.002026-09-23
Core One Labs stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-09-14
1 month+0%USD 0.002026-08-14
3 month+0%USD 0.002026-06-25
Year to date-90%USD 0.002025-12-17
1 year-100%USD 0.022025-09-23
3 year-100%USD 0.292023-09-22
5 year-100%USD 1.802021-09-24
Since inception-100%USD 15.072015-06-25

Core One Labs Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$198.71K

Net Income (TTM)

-CA$14.44M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-74.70 (Low)

Price

$0.00

Volume

550

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Jun 14, 2024

CLABF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Core One Labs

Core One Labs Inc. operates as a psychedelic research and development company, focusing on innovative delivery systems for psychedelic medicines and psychotherapy. The company aims to advance technology related to compounds like psilocybin while also providing natural health products and medical services.

Products and Services
  • Development of psychedelic medicines and delivery systems
  • Psychedelic-assisted psychotherapy services
  • Natural health products and medical clinic operations
Growth Outlook
  • Increasing interest in psychedelic therapies is driving market potential
  • Expansion into medical clinics enhances service offerings and revenue streams
  • Research initiatives aim to position the company as a leader in the sector
Financial Highlights
  • Recent quarterly revenue of CAD 93,661 shows growth from previous quarters
  • Trailing twelve months (TTM) gross profit margin stands at 90.8%
  • Cash and short-term investments totaled CAD 154,816 as of Q4 2023
Core One Labs Inc. is strategically positioned in the burgeoning field of psychedelic research, which is gaining traction as a viable treatment option for various mental health conditions. The company's focus on innovative delivery systems and psychotherapy services aligns with the growing acceptance of psychedelics in mainstream medicine. Recent financial data indicates a positive trajectory, with revenue growth and a strong gross profit margin, suggesting effective cost management and operational efficiency. The company's cash reserves provide a solid foundation for future investments and expansion efforts, making it an intriguing option for investors interested in the evolving healthcare landscape.
AI Generated • Oct 2, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Joel Shacker

Website

www.core1labs.com

Headquarters

Vancouver, BC V6E 3T5, CA

CLABF Financials

Key Financial Metrics (TTM)

Gross Margin

90.80%

Operating Margin

-1709.20%

Net Income Margin

-3485.36%

Return on Equity

-289.95%

Return on Capital

-116.71%

Return on Assets

-196.98%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

550

Avg. Volume

676.828

Financials (TTM)

Gross Profit

CA$177.19K

Operating Income

-CA$5.10M

EBITDA

-CA$5.49M

Operating Cash Flow

-CA$1.46M

Capital Expenditure

-CA$21.15K

Free Cash Flow

-CA$1.48M

Cash & ST Invst.

CA$154.82K

Total Debt

CA$250.00K

Core One Labs Performance Analysis

Core One Labs annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31CAD 344,265N/A
20222022-12-31CAD 497,81944.6%
20232023-03-31CAD 346,548-30.4%
Core One Labs sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12023-03-31-121.6%
Q22023-06-30261.4%
Q32023-09-30-24.8%
Q42023-12-3134.3%
Core One Labs annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31CAD -2.05N/A
20222022-12-31CAD -0.40-80.5%
20232023-03-31CAD -0.37-7.5%
Core One Labs sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12023-03-31-247.5%
Q22023-06-3096.4%
Q32023-09-30-174.2%
Q42023-12-3129.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2023YOY CHG

Revenue

CA$93.66K

-64.9%

Gross Profit

CA$93.66K

-62.6%

Gross Margin

100.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

192

N/A

Net Income

-CA$840.66K

+69.8%

EBITDA

-CA$833.10K

+61.9%

Quarterly Fundamentals

Name
Q4 2023YOY CHG

Total Cash

CA$154.82K

-90.8%

Total Debt

CA$250.00K

-10.7%

Accounts Receivable

CA$224.73K

+43.8%

Inventory

CA$1.38K

-59.5%

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$250.00K

-10.7%

Return on Assets

-1.97%

N/A

Return on Invested Capital

-1.17%

N/A

Free Cash Flow

-CA$73.74

+100.0%

Operating Cash Flow

-CA$73.74

+100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FNAMEvolutionary Genomics, Inc.
$0.00+0.00%
ENZNViskase Companies, Inc.
$4.71+1.29%
SRNESorrento Therapeutics, Inc.
$0.00+0.00%
CNGGFCann Group Limited
$0.00-20.42%

Trending Stocks

Symbol / CompanyPricePrice Chg
NKENike
$33.87-3.64%
NVDANvidia
$233.95+1.34%
SPCXSpace Exploration Technologies
$158.96+7.36%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$29.71-6.46%

Questions About CLABF

What is the current price of Core One Labs?

Core One Labs is trading at $0.00 per share.

What is the 52-week range for Core One Labs?

Over the past 52 weeks, Core One Labs has traded between $0.00 and $0.01.

How much debt does Core One Labs have?

As of the most recent reporting period, Core One Labs reported total debt of CA$0.00.

How much cash does Core One Labs have on hand?

Core One Labs reported CA$462.91K in cash and cash equivalents in its most recent financial results.

What is Core One Labs’s dividend yield?

Core One Labs does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services